statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA  Get Free Report) was the recipient of a significant growth in short interest in the month of March. As of March 15th, there was short interest...

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Short Interest Update

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the Company or IPA) (NASDAQ: IPA), InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability...

InterSystems and IPAs Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications

Immunoprecise Antibodies partners with InterSystems to integrate Vector Search of IRIS data platform with BioStrand's LENSai for AI-driven healthcare solutions. Revolutionize drug discovery with...

EXCLUSIVE: Immunoprecise Antibodies and InterSystems Integrate Vector Search With LENSai For AI-Driven Healthcare Applications

Immunoprecise Antibodies Ltd. (IPA) has released an update. Immunoprecise Antibodies Ltd. (IPA) has allied with InterSystems to advance AI-driven h...

IPA and InterSystems Partner for AI-Driven Healthcare

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the Company or IPA) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today announced that it has acquired the LSA...

IPA Acquires the Carterra LSA Instrument to Enhance Antibody Discovery and Bolster Its AI Developments

Benchmark reaffirmed their speculative buy rating on shares of ImmunoPrecise Antibodies (NASDAQ:IPA  Free Report) in a report published on Friday morning, Benzinga reports. The firm currently...

ImmunoPrecise Antibodies (NASDAQ:IPA) Receives Speculative Buy Rating from Benchmark

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA  Get Free Report) was the recipient of a significant drop in short interest during the month of February. As of February 29th, there was short...

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Short Interest Down 37.6% in February

Q3 2024 Immunoprecise Antibodies Ltd Earnings Call Transcript

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the Company or IPA) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today reported financial results for its...

IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024*

VICTORIA, BC / ACCESSWIRE / March 8, 2024 / Anyone familiar with the intricacies of life science knows how truly complicated DNA is; without a full understanding of the language of DNA, scientists...

ImmunoPrecise Antibodies (NASDAQ:IPA) Subsidiary BioStrand Introduces Breakthrough AI Model In Life Sciences, Harnessing LLM Stacking And HYFT Technology

ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The firm offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.

Watchers	3,235
52-Wk Low	$0.94
52-Wk High	$4.22

Volume	58,744.00
52-Wk High	$4.22
52-Wk Low	$0.94

IPA ImmunoPrecise Antibodies Ltd

About

Feed

News

Earnings

Fundamentals